Oncology & Cancer

AGO2 in T-prolymphocytic leukemia (T-PLL)

A new editorial paper titled "AGO2 in T-prolymphocytic leukemia: its canonical and noncanonical deregulation and function" has been published in Oncotarget.

Medications

Belly fat hinders digestive disease medications

The mass and composition of our bodies can significantly affect the way medications are metabolized and absorbed. Investigators at Cedars-Sinai have found that inflammatory bowel disease (IBD) patients with higher levels ...

page 14 from 40